Ruxolitinib-Associated Infections in Polycythemia Vera: Review of the Literature, Clinical Significance, and Recommendations

SIMPLE SUMMARY: Polycythemia vera (PV) is a chronic blood disease characterized by elevated red blood cells and splenomegaly. About 98% of all PV patients harbor the JAK2 mutation. Ruxolitinib (RUX), a JAK1/JAK2 inhibitor, received approval as a second-line indication in PV patients who are resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadjadian, Parvis, Wille, Kai, Griesshammer, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693745/
https://www.ncbi.nlm.nih.gov/pubmed/33114733
http://dx.doi.org/10.3390/cancers12113132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693745/
https://www.ncbi.nlm.nih.gov/pubmed/33114733
http://dx.doi.org/10.3390/cancers12113132

Ejemplares similares